These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 10404937)

  • 1. Management of the older person with ventricular arrhythmias.
    Aronow WS
    J Am Geriatr Soc; 1999 Jul; 47(7):886-95. PubMed ID: 10404937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of ventricular arrhythmias in older adults.
    Aronow WS
    J Am Geriatr Soc; 1995 Jun; 43(6):688-95. PubMed ID: 7539822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of older persons after myocardial infarction.
    Aronow WS
    J Am Geriatr Soc; 1998 Nov; 46(11):1459-68. PubMed ID: 9809771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The management of ventricular arrhythmias in older patients after CAST.
    Aronow WS
    Drugs Aging; 1995 Feb; 6(2):112-24. PubMed ID: 7711358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of patients with life-threatening sustained ventricular tachyarrhythmias--the role of guided antiarrhythmic drug therapy.
    Steinbeck G; Greene HL
    Prog Cardiovasc Dis; 1996; 38(6):419-28. PubMed ID: 8638023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of the older person with atrial fibrillation.
    Aronow WS
    J Am Geriatr Soc; 1999 Jun; 47(6):740-8. PubMed ID: 10366178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of ventricular arrhythmias.
    Aronow WS
    Minerva Cardioangiol; 2010 Dec; 58(6):657-76. PubMed ID: 21135807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of ventricular arrhythmias in the elderly.
    Aronow WS
    Cardiol Rev; 2009; 17(3):136-46. PubMed ID: 19384088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Heart failure].
    Yonezawa M; Komuro I
    Nihon Rinsho; 2002 Jul; 60(7):1422-6. PubMed ID: 12136624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beta-blocker use and survival in patients with ventricular fibrillation or symptomatic ventricular tachycardia: the Antiarrhythmics Versus Implantable Defibrillators (AVID) trial.
    Exner DV; Reiffel JA; Epstein AE; Ledingham R; Reiter MJ; Yao Q; Duff HJ; Follmann D; Schron E; Greene HL; Carlson MD; Brodsky MA; Akiyama T; Baessler C; Anderson JL
    J Am Coll Cardiol; 1999 Aug; 34(2):325-33. PubMed ID: 10440140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Absence of a morning peak in ventricular tachycardia and fibrillation events in nonischemic heart disease: analysis of therapies by implantable cardioverter defibrillators.
    Taneda K; Aizawa Y;
    Pacing Clin Electrophysiol; 2001 Nov; 24(11):1602-6. PubMed ID: 11816628
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A focus on when and when not to use antiarrhythmic drugs in treating ventricular arrhythmias and indications for the use of automatic implantable cardioverter-defibrillators.
    Aronow WS
    Geriatrics; 2008 Aug; 63(8):20-8. PubMed ID: 18672953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The amiodarone-beta blockers combination could represent an alternative treatment in patients at risk for sudden death in which a benefit from implantable defibrillators has not been clearly demonstrated].
    Alboni P
    Ital Heart J Suppl; 2002 Mar; 3(3):337-43. PubMed ID: 12040849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias.
    Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators
    N Engl J Med; 1997 Nov; 337(22):1576-83. PubMed ID: 9411221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of ventricular arrhythmias.
    Aronow WS
    Compr Ther; 2008; 34(2):89-99. PubMed ID: 18833785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dofetilide reduces the frequency of ventricular arrhythmias and implantable cardioverter defibrillator therapies.
    Baquero GA; Banchs JE; Depalma S; Young SK; Penny-Peterson ED; Samii SM; Wolbrette DL; Naccarelli GV; Gonzalez MD
    J Cardiovasc Electrophysiol; 2012 Mar; 23(3):296-301. PubMed ID: 21955243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lessons from antiarrhythmic trials involving class III antiarrhythmic drugs.
    Yap YG; Camm AJ
    Am J Cardiol; 1999 Nov; 84(9A):83R-89R. PubMed ID: 10568665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological therapy in coronary heart disease: prevention of life-threatening ventricular tachyarrhythmias and sudden cardiac death.
    Kochs M; Eggeling T; Hombach V
    Eur Heart J; 1993 Sep; 14 Suppl E():107-19. PubMed ID: 8223747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implantable cardioverter-defibrillators.
    Aronow WS
    Am J Ther; 2010; 17(6):e208-20. PubMed ID: 19918166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Ventricular arrhythmias after myocardial infarction: risk classification and treatment concepts].
    Seidl K; Hauer B; Schwick N; Buechele T; Schilling I; Senges J
    Dtsch Med Wochenschr; 1995 May; 120(18):656-60. PubMed ID: 7750434
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.